To The Administration
HLC response to Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
- Topics: Health Information Technology, Innovation, Value-Based Care
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
To The Administration
HLC comments support strengthening intellectual property provisions of USMACA
To The Administration
HLC response to the Federal Trade Commission’s RFI regarding noncompete agreements
To Congress
